MKS Instruments (MKSI) Tops Q1 EPS by 27c; offers guidance

MKS Instruments (NASDAQ: MKSI) reported Q1 EPS of $1.71, $0.27 better than the analyst estimate of $1.44. Revenue for the quarter came in at $936 million versus the consensus estimate of $915.12 million.

GUIDANCE:

MKS Instruments sees Q2 2025 EPS of $1.56 plus or minus $0.28, versus the consensus of $1.67. MKS Instruments sees Q2 2025 revenue of $925 million plus or minus $40 million, versus the consensus of $938.5 million.

For earnings history and earnings-related data on MKS Instruments (MKSI) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• Northrop Grumman wins $143M in new U.S. defense contracts
• NeuroSense posts narrower H1 loss, targets Canada drug filing by December